For research use only. Not for therapeutic Use.
3-Hydroxy agomelatine-d3(Cat No.:S000476) is a deuterated form of 3-Hydroxy agomelatine, where three hydrogen atoms are replaced with deuterium. This modification aims to study the compound’s metabolic stability and pharmacokinetics in greater detail. 3-Hydroxy agomelatine is a metabolite of agomelatine, a medication primarily used to treat major depressive disorder. Agomelatine functions as a melatonin receptor agonist and a 5-HT2C receptor antagonist, influencing circadian rhythms and mood regulation. The deuterated version, 3-Hydroxy agomelatine-d3, helps researchers understand how the body processes and breaks down the drug, providing insights into its efficacy and safety profile.
Catalog Number | S000476 |
CAS Number | 1079774-23-4 |
Molecular Formula | C15H14D3NO3 |
Purity | ≥95% |
Target | Neuronal Signaling |
IUPAC Name | N-[2-[3-hydroxy-7-(trideuteriomethoxy)naphthalen-1-yl]ethyl]acetamide |
InChI | InChI=1S/C15H17NO3/c1-10(17)16-6-5-12-8-13(18)7-11-3-4-14(19-2)9-15(11)12/h3-4,7-9,18H,5-6H2,1-2H3,(H,16,17)/i2D3 |
InChIKey | VUBBOOVHTBZRTJ-BMSJAHLVSA-N |
SMILES | CC(=O)NCCC1=C2C=C(C=CC2=CC(=C1)O)OC |